|
Volumn 19, Issue 5, 2013, Pages 1300-
|
Colon cancer mutation: Prognosis/prediction-letter
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
COLON CANCER;
DISEASE FREE SURVIVAL;
DRUG EFFICACY;
DRUG RESISTANCE;
DRUG RESPONSE;
DRUG SENSITIVITY;
GENE MUTATION;
HUMAN;
LETTER;
MISMATCH REPAIR;
OVERALL SURVIVAL;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PROGNOSIS;
COLONIC NEOPLASMS;
HUMANS;
MICROSATELLITE INSTABILITY;
MUTATION;
|
EID: 84874881266
PISSN: 10780432
EISSN: 15573265
Source Type: Journal
DOI: 10.1158/1078-0432.CCR-12-3765 Document Type: Letter |
Times cited : (3)
|
References (5)
|